Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company’s best-in-class product offerings include Arteriocyte’s market-leading Magellan® Autologous Platelet Separator and Isto’s bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; and Influx™, a natural bone-graft material.
Company’s Keywords:
biotechnology, life sciences, orthobiologics, medical device, products for spine & orthopedics, bone grafts, celltherapy, regenerative medicine, minimally invasive spine & orthopedic solutions, spinal disc regeneration, platelet rich plasma
110
medical devices
25000000
SparkPost, Outlook, Amazon AWS, Google Tag Manager, Google Font API, Mobile Friendly, Varnish, Hotjar, Linkedin Marketing Solutions, Bootstrap Framework
1997